Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000611453 | SCV000722894 | likely benign | not specified | 2017-09-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001054943 | SCV001219302 | likely benign | RASopathy | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000611453 | SCV003923213 | benign | not specified | 2023-03-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003302944 | SCV003998762 | likely benign | Cardiovascular phenotype | 2023-03-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003884662 | SCV004702624 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | MAP2K2: BP4, BP7 |